Clinical factors associated with increase in serum transthyretin levels at 1-year with tafamidis in wild-type transthyretin amyloid cardiomyopathy

Journal of Cardiology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles